MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-16884

  1. 15,454 Posts.
    lightbulb Created with Sketch. 5535
    Nope didn't miss any of them ..... the word "productive" is mentioned only once in all 3 documents you've listed and that wasn't in reference to any FDA meeting so again where did you see this 'productive' reference you highlighted in your post in reference to the CHF meeting that Mesoblast has supposedly already had ?


    Just looks like more made up nonsense by you given there is no reference of FDA meetings being "productive" as you try to claim ?



    69651241

    upload_2023-10-2_11-28-19.png
    (Page 48) Being diverse makes us more creative, flexible, and productive. Mesoblast’s policy is to engage the most appropriate



    69651511
    upload_2023-10-2_11-30-30.png


    69651658

    upload_2023-10-2_11-32-10.png




    upload_2023-10-2_11-25-50.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.